PFM
SOPH icon

Privium Fund Management’s SOPHiA GENETICS SOPH Stock Holding History

Privium Fund Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,080
Closed -$140K – 127
2023
Q4 		$140K Hold
29,080
– – 0.04% 80
2023
Q3 		$74.2K Hold
29,080
– – 0.02% 84
2023
Q2 		$120K Hold
29,080
– – 0.03% 79
2023
Q1 		$145K Hold
29,080
– – 0.05% 77
2022
Q4 		$65.4K Buy
29,080
+1,000
+4% +$2.25K 0.02% 87
2022
Q3 		$74K Hold
28,080
– – 0.03% 125
2022
Q2 		$102K Buy
+28,080
New +$142K 0.03% 125

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Privium Fund Management's SOPH Position: Q1 2024 in Review

Privium Fund Management sold out of SOPHiA GENETICS (SOPH) in Q1 2024, closing a stake of 29,080 shares — an estimated $140K sold.

Privium Fund Management first reported a position in SOPH in Q2 2022 and held it in 7 quarters. The position peaked at $145K in Q1 2023. 32 funds tracked by Wall St. Rank hold SOPH as of Q1 2024.

  • Privium Fund Management reported no remaining SOPHiA GENETICS position as of Q1 2024 after selling out during the quarter.
  • Privium Fund Management sold 29,080 SOPHiA GENETICS shares in Q1 2024, an estimated $140K.
  • Privium Fund Management first reported a position in SOPHiA GENETICS in Q2 2022 and held it in 7 quarters.
  • Privium Fund Management's SOPHiA GENETICS position peaked at $145K in Q1 2023.
  • 32 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2024.

Based on Privium Fund Management's 13F filing for Q1 2024, filed 30 Apr 2024.